Targeted therapies to eliminate cancer stem cells in solid tumors.
ACQUIRED BY ABBVIE 2016
Non-invasive cardiovascular health diagnostics.
A multiomics platform connecting people with next-generation blood tests for early cancer detection.
Identifying any microbe from any sample, anywhere in the world.
ACQUIRED BY ILLUMINA 2022
A future where animal products are animal-free.
Precision elimination of multi-antibiotic resistant infectious bacteria.
Reimagining cell function through protein design to enable curative cell therapies.
Improving access to mental health care through telemedicine, online care and medication management.
Bringing marketplace efficiencies to healthcare services.
Curing disease by writing in the
code of life
Pioneering applications of bacteria to impact human and environmental health.
CRISPR-based therapies to cure viral infectious diseases.
Hardware-agnostic surgical software that allows surgical systems to collaborate with surgeons.
A full-stack solution to shift patient
ACQUIRED BY 23ANDME 2021
Transforming the lives of patients with insulin-requiring diabetes.
ACQUIRED BY VERTEX 2022
Non-hallucinogenic analogs to change the way we treat brain disorders.
Enabling novel insights into biology and disease through next-generation protein sequencing
Reprogramming biology by writing and delivering big DNA
Empowering radiologists with AI to save time, reduce burnout, and improve patient care